Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin
- 1 September 1999
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 144 (1) , 39-43
- https://doi.org/10.1016/s0304-3835(99)00188-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- In vitroAntigenotoxic Activity of Novel Ginseng Saponin Metabolites Formed by Intestinal BacteriaPlanta Medica, 1998
- Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer CellsJapanese Journal of Cancer Research, 1998
- An Intestinal Bacterial Metabolite of Ginseng Protopanaxadiol Saponins Has the Ability to Induce Apoptosis in Tumor CellsBiochemical and Biophysical Research Communications, 1998
- Role of Human IntestinalPrevotella orisin Hydrolyzing Ginseng SaponinsPlanta Medica, 1997
- Main Ginseng Saponin Metabolites Formed by Intestinal BacteriaPlanta Medica, 1996
- Inhibitory Effect of Some Triterpenoid Saponins on Glucose Transport in Tumor Cells and its Application toin vitroCytotoxic and Antiviral ActivitiesPlanta Medica, 1994
- Antitumor activity of thaliblastine (NSC-68075) in experimental ovarian tumor cell lines sensitive and resistant to cisplatinCancer Letters, 1992
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991
- Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivoAnti-Cancer Drugs, 1991
- Establishment and characterization of cisplatin‐resistant sublines of human lung cancer cell linesInternational Journal of Cancer, 1988